Global CRISPR Technology Market

Focus on Product, Applications, Geographical Analysis, Industry Insights And Competitive Landscape - Analysis And Forecast (2018-2027)

Published Year:
SKU:BH00576SA
View TOCGet Free Sample
Get Customization, Data Extraction and Value Added Services with All BIS Research Reports
Know More

$4599

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Report Description

The advent of CRISPR technology has transformed the field of genome editing and paved pathways for development of several gene the

The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophilia, and sickle cell anaemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.

The CRISPR technology include designing tools, library, control kits, plasmids, vectors, proteins, gRNA and other products to perform the desired experiment and study the obtained results. Currently, CRISPR technology is considered a valuable tool for the biotechnology and biopharmaceutical companies to conduct cost effective and highly efficient genome editing procedures. Moreover, advancements of CRISPR technology reduced turn-around time and complexity of genome editing process. The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders. The pharmaceutical industry is witnessing the growth of pipeline of candidates developed using CRISPR technology. Several biopharmaceutical companies are now indulging in the research and development of such CRISPR based therapies. Furthermore, the advent of genome editing technologies in molecular research has enabled the companies to target the root cause of genetic and chronic diseases, with one-time procedure and develop gene therapeutics to remain competitive in the market.

The purpose of this study is to gain a holistic view of the CRISPR technology market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products associated with the global CRISPR technology market, across different regions. The market has been segmented into ‘product’, ‘application’, and ‘regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global CRISPR technology market with the help of the key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well. 

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global CRISPR technology market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment the key market trends, list of the key companies, and the key strategies and developments, have been discussed.

The key players who have been contributing significantly to the CRISPR technology market include Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., Horizon Discovery plc, EdiGene, Inc., GeneCopoeia, Inc., Genedata AG, GenScript, Integrated DNA Technologies (IDT), Inc., Mirus Bio LLC, New England Biolabs, OriGene Technologies, Inc., Oxford Genetics Ltd., Rockland Immunochemicals, Inc., Merck KGaA, Synthego Corporation, System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific, transOMIC technologies inc., and Transposagen Biopharmaceuticals, among others.

Read More

Key Questions Answered in this Report

How did the CRISPR technology market evolve, and what is its scope in the future?

The answers to the following key questions can be derived from this report:

•    How did the CRISPR technology market evolve, and what is its scope in the future?
•    What are the major market drivers, challenges and opportunities in the global CRISPR technology market?
•    What are the key developmental strategies that are being implemented by the key players to sustain in this market?
•    How are the influencing factors will affect the industry attractiveness?
•    How the CRISPR technology is being utilized for the development of therapeutics?
•    How the investments by public & private companies, and government organizations will affect the global CRISPR technology market? 
•    What was the market size of the leading segments and sub-segments of the global CRISPR technology market in 2017?
•    How will the industry evolve during the forecast period 2018- 2027?
•    What will be the growth rate of the CRISPR technology during the forecast period?
•    How will each segment of the global CRISPR technology market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2027?
•    Which product segment, and application segment is expected to register the highest CAGR for the CRISPR technology market?
•    What are the major benefits of the implementation of CRISPR technology in different field of applications including biological research, agricultural biotech, industrial biotech, and therapeutics & drug discovery?
•    What is the market size of CRISPR technology in different countries of the world?
•    Which geographical region will contribute to the highest sales of CRISPR technology?
•    Who are the key players in the CRISPR technology market and what are their contributions?

Read More

Market Overview

The advent of CRISPR technology has transformed the field of genome editing and paved pathways for development of several gene the

Every year, around 7.9 million children are born with genetic disorders, worldwide. Also, the genetic diseases have been responsible for 20-30% of the infant’s deaths worldwide and constitute approximately 25% of the global economic burden for diseases. The increasing economic burden of genetic diseases can be reduced by focusing on gene therapeutics supported by biomarker study, lifestyle modification, and disease screening methods that enable early detection. Furthermore, the increasing environmental factors, such as chemical factors, radioactive factors, and biological factors, has elevated the mutation rate, which elevated the need for the development of best gene therapeutic procedures, personalized medicine, and diagnostic procedures with less turnaround time. 

Several conglomerate companies and startups based out of the developed countries, such as the U.S., the U.K., Germany, China, France, and Canada, among others, have been making significant investments in the field of life sciences to develop promising gene therapy procedures to promote global health. The advent of CRISPR technology has transformed the field of genome editing by reducing the turnaround time and complexity, enhancing the accuracy, efficiency, and safety, and encouraged numerous innovations. Researchers demonstrated the potential applications of CRISPR technology to provide one-time gene therapy procedure for several genetic disorders, such as haemophilia, sickle cell anemia, and beta thalassemia, and cancers. Also, the CRISPR technology proved to repair genetic errors in an individual’s DNA, treating the root cause of the disease. Many companies, such as CRISPR Therapeutics AG, are planning to initiate clinical trials in 2018 for the treatment of various genetic disorders.

The purpose of the study is to gain a holistic view of the CRISPR technology market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the products associated with the global CRISPR technology market, across different regions. The global CRISPR technology market is segmented into three different parts namely by product, by application, and by region. The global market value was estimated using these three different approaches and was validated with one another. The global CRISPR technology market is expected to reach $10.55 billion by 2027. 

With the increasing demand for advancements in application specific products across the various segments of the CRISPR technology, the CRISPR technology market is expected to witness rapid growth in the future. Further, the swift expansion of the gene therapy procedures in the developed markets such as the U.S., Japan, Germany, and the U.K. is the key driver for growth of the CRISPR technology market. Moreover, the plasmids sub-segment dominated the global CRISPR technology market in 2017 in terms of products. However, the proteins sub segment is anticipated to witness the highest CAGR during the forecast period. The therapeutics and drug discovery application specific CRISPR technology witnessed the highest industry demand. Besides, the CRISPR technology specific to industrial biotech are also expected to witness impressive CAGR during the forecast period.

Based on the region the global CRISPR technology market is segmented into North America, Europe, Asia Pacific and Rest of the World (RoW). North America is the leading contributor to the global CRISPR technology market and contributed 39% of the global market values in 2017. However, Europe is expected to grow at a CAGR of 36.80% during the forecast period followed by Asia Pacific region.

The key players who have significant contributions to the global CRISPR technology market are Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., Horizon Discovery plc, EdiGene, Inc., GeneCopoeia, Inc., Genedata AG, GenScript, Integrated DNA Technologies (IDT), Inc., Mirus Bio LLC, New England Biolabs, OriGene Technologies, Inc., Oxford Genetics Ltd., Rockland Immunochemicals, Inc., Merck KGaA, Synthego Corporation, System Biosciences, LLC, Thermo Fisher Scientific, transOMIC technologies inc., and Transposagen Biopharmaceuticals, among others.

Read More

Table of Contents

Get Free Sample

1.1    Introduction
1.2    CRISPR Technology Approach
1.3    Evolution of CRISPR Technology
1.4    CRISPR Technology: Areas of Interest
1.5    CRISPR Technology: Future Potential
1.6    Global Market
1.7    Assumptions and Limitations

2.1    Overview
2.2    Impact Analysis
2.3    Market Drivers
2.4    Market Restraints
2.5    Market Opportunities

3.1    Introduction
3.2    Key Developments and Strategies
3.3    Product Launches and Enhancements
3.4    Joint Ventures, Partnerships and Collaborations
3.5    Mergers and Acquisitions
3.6    Business Expansions, Awards, Recognitions, Certifications and Others
3.7    Industry Attractiveness
        3.7.1    Bargaining Power of Suppliers
        3.7.2    Bargaining Power of Buyers
        3.7.3    Threat of New Entrants
        3.7.4    Threat of Substitute Products
        3.7.5    Intensity of Competitive Rivalry
3.8    Pipeline Analysis

4.1    Introduction
4.2    Patent Analysis
4.3    Funding Scenario
         4.3.1    Funding Scenario: Public Companies
         4.3.2    Funding Scenario: Private Companies
         4.3.3    Funding Scenario: Investments by Government Organizations
4.4    Legal Requirements and Regulations
4.5    List of Regulatory Bodies

5.1    Overview
5.2    Designing Tools
5.3    Library
5.4    Control Kits
5.5    Plasmids
5.6    Vectors
5.7    Proteins
        5.7.1    Cas9
        5.7.2    Cpf1
        5.7.3    Others
5.8    Grna
5.9    Others

6.1    Overview
6.2    Biological Research
6.3    Agricultural Biotech
6.4    Industrial Biotech
6.5    Therapeutics and Drug Discovery

7.1    Overview
7.2    Global Insights
7.3    North America
        7.3.1    North America Market Dynamics
        7.3.2    North America Market, by Country
                7.3.2.1    The U.S.
                7.3.2.2    Canada
7.4    Europe
        7.4.1    Europe Market Dynamics
        7.4.2    Europe Market, by Country
                7.4.2.1    The U.K.
                7.4.2.2    Germany
                7.4.2.3    France
                7.4.2.4    Spain
                7.4.2.5    Italy
                7.4.2.6    Switzerland
                7.4.2.7    Rest of the Europe
7..5    Asia Pacific
        7.5.1    Asia Pacific Market Dynamics
        7.5.2    Asia Pacific, by Country
                7.5.2.1    Japan
                7.5.2.2    China
                7.5.2.3    South Korea
                7.5.2.4    Singapore
                7.5.2.5    India
                7.5.2.6    Rest of Asia Pacific
7.6    Rest of the World

8.1    Agilent Technologies, Inc.
8.1.1    Overview
8.1.2    Overall Product Portfolio
8.1.3    Product Offerings for Global CRISPR Technology Market
8.1.4    Financials
8.1.4.1    Financial Summary
8.1.5    Global Presence
8.1.6    Recent Developments
8.1.7    SWOT Analysis
8.2    Applied StemCell, Inc.
8.2.1    Overview
8.2.2    Corporate Summary
8.2.3    Product Offerings for Global CRISPR Technology Market
8.2.4    Recent Developments
8.2.5    SWOT Analysis
8.3    Cellecta, Inc.
8.3.1    Overview
8.3.2    Corporate Summary
8.3.3    Product Offerings for Global CRISPR Technology Market
8.3.4    SWOT Analysis
8.4    Dharmacon, Inc.
8.4.1    Overview
8.4.2    Overall Product Portfolio
8.4.3    Product Offerings for Global CRISPR Technology Market
8.4.4    Financials
8.4.4.1    Financial Summary
8.4.5    Global Presence
8.4.6    Recent Developments
8.4.7    SWOT Analysis
8.5    DiaCarta, Inc.
8.5.1    Overview
8.5.2    Corporate Summary
8.5.3    Product Offerings for Global CRISPR Technology Market
8.5.4    Global Presence
8.5.5    Recent Developments
8.5.6    SWOT Analysis
8.6    EdiGene, Inc.
8.6.1    Overview
8.6.2    Corporate Summary
8.6.3    Product Offerings for Global CRISPR Technology Market
8.6.4    Recent Developments
8.6.5    SWOT Analysis
8.7    GeneCopoeia, Inc.
8.7.1    Overview
8.7.2    Corporate Summary
8.7.3    Product Offerings for Global CRISPR Technology Market
8.7.4    SWOT Analysis
8.8    Genedata AG
8.8.1    Overview
8.8.2    Corporate Summary
8.8.3    Product Offerings for Global CRISPR Technology Market
8.8.4    Recent Developments
8.8.5    SWOT Analysis
8.9    GenScript
8.9.1    Overview
8.9.2    Overall Product Portfolio
8.9.3    Product Offerings for Global CRISPR Technology Market
8.9.4    Financials
8.9.4.1    Financial Summary
8.9.5    Global Presence
8.9.6    Recent Developments
8.9.7    SWOT Analysis
8.10    Integrated DNA Technologies (IDT), Inc.
8.10.1    Overview
8.10.2    Corporate Summary
8.10.3    Product Offerings for Global CRISPR Technology Market
8.10.4    Recent Developments
8.10.5    SWOT Analysis
8.11    Mirus Bio LLC
8.11.1    Overview
8.11.2    Corporate Summary
8.11.3    Product Offerings for Global CRISPR Technology Market
8.11.4    Recent Developments
8.11.5    SWOT Analysis
8.12    New England Biolabs
8.12.1    Overview
8.12.2    Corporate Summary
8.12.3    Product Offerings for Global CRISPR Technology Market
8.12.4    SWOT Analysis
8.13    OriGene Technologies, Inc.
8.13.1    Overview
8.13.2    Corporate Summary
8.13.3    Product Offerings for Global CRISPR Technology Market
8.13.4    Recent Developments
8.13.5    SWOT Analysis
8.14    Oxford Genetics Ltd.
8.14.1    Overview
8.14.2    Corporate Summary
8.14.3    Product Offerings for Global CRISPR Technology Market
8.14.4    Recent Developments
8.14.5    SWOT Analysis
8.15    Rockland Immunochemicals, Inc.
8.15.1    Overview
8.15.2    Corporate Summary
8.15.3    Product Offerings for Global CRISPR Technology Market
8.15.4    SWOT Analysis
8.16    Sigma Aldrich Corporation (A Subsidiary of Merck KGaA)
8.16.1    Overview
8.16.2    Overall Product Portfolio
8.16.3    Product Offerings for Global CRISPR Technology Market
8.16.4    Financials
8.16.4.1    Financial Summary
8.16.5    Global Presence
8.16.6    Recent Developments
8.16.7    SWOT Analysis
8.17    Synthego Corporation
8.17.1    Overview
8.17.2    Corporate Summary
8.17.3    Product Offerings for Global CRISPR Technology Market
8.17.4    Recent Developments
8.17.5    SWOT Analysis
8.18    System Biosciences, LLC
8.18.1    Overview
8.18.2    Corporate Summary
8.18.3    Product Offerings for Global CRISPR Technology Market
8.18.4    SWOT Analysis
8.19    Takara Bio USA Inc. (A Subsidiary of Takara Bio Inc.)
8.19.1    Overview
8.19.2    Overall Product Portfolio
8.19.3    Product Offerings for Global CRISPR Technology Market
8.19.4    Financials
8.19.4.1    Financial Summary
8.19.5    Global Presence
8.19.6    Recent Developments
8.19.7    SWOT Analysis
8.20    Thermo Fisher Scientific Inc.
8.20.1    Overview
8.20.2    Overall Product Portfolio
8.20.3    Product Offerings for Global CRISPR Technology Market
8.20.4    Financials
8.20.4.1    Financial Summary
8.20.5    Global Presence
8.20.6    Recent Developments
8.20.7    SWOT Analysis
8.21    transOMIC technologies inc.
8.21.1    Overview
8.21.2    Corporate Summary
8.21.3    Product Offerings for Global CRISPR Technology Market
8.21.4    Recent Developments
8.21.5    SWOT Analysis
8.22    Transposagen Biopharmaceuticals
8.22.1    Overview
8.22.2    Corporate Summary
8.22.3    Product Offerings for Global CRISPR Technology Market
8.22.4    SWOT Analysis

9.1    Scope of the Report
9.2    Global CRISPR Technology Market Segmentation
9.3    Research Methodology
        9.3.1    Primary Research
        9.3.2    Secondary Research
        9.3.3    Key Data Points from Primary Sources
        9.3.4    Key Data Points from Secondary Sources
        9.3.5    Data Triangulation
        9.3.6    Top-Down Approach (Segment wise Analysis)
        9.3.7    Bottom-Up Approach (Segmental Analysis)
9.4    Assumptions and Limitations
9.5    Data and Prediction Modelling

10.1    Annexure 1: Recent Key Developments (2014 – 2018) and Patent Landscape
10.2    Annexure 2: Product Mapping and Pricing Analysis

1    Global CRISPR Technology Market (2017 & 2027)
2    Impact Analysis of Market Dynamics
3    Pipeline Analysis of Biopharmaceutical Companies using CRISPR Technology
4    Funding Scenario of Public Companies
5    Funding Scenario of Private Companies
6    Funding Scenario of Government Organizations
7    List of Regulatory Bodies
8    Europe CRISPR Technology Market, by Country, $Million (2017-2027)
9    Asia Pacific CRISPR Technology Market, by Country, $Million (2017-2027)
10    Agilent Technologies, Inc.: Product Developments
11    Applied StemCell, Inc.: Other Developments
12    Applied StemCell, Inc.: Merger And Acquisition
13    Horizon Discovery plc: Product Developments
14    Horizon Discovery plc: Merger, Acquisition & Collaboration 
15    EdiGene, Inc.: Agreements and Other Developments
16    Genedata AG: Agreements and Collaboration
17    Genedata AG: Product Developments
18    Genedata AG: Other Developments
19    GenScript: Product Developments
20    Integrated DNA Technologies, Inc.: Product Developments
21    Integrated DNA Technologies, Inc.: Merger and Acquisition
22    Mirus Bio LLC: Product Developments
23    OriGene Technologies, Inc.: Product Developments
24    Oxford Genetics Ltd.: Agreements and Other Developments
25    Merck KGaA: Partnerships, Collaboration, Acquisition and Joint Venture
26    Merck KGaA: Other Developments
27    Synthego Corporation: Product Developments
28    Synthego Corporation : Other Developments
29    Takara Bio USA Inc.: Product Developments
30    Takara Bio USA Inc.: Merger and Acquisition
31    Thermo Fisher Scientific Inc.: Product Developments
32    Thermo Fisher Scientific Inc.: Merger and Acquisition
33    transOMIC technologies inc.: Product Developments

1    Impact of Market Drivers and Market Restraints
2    Market Statistics
3    Global CRISPR Technology Market, by Product ($Million)
4    Global CRISPR Technology Market, by Product, 2017
5    Global CRISPR Technology Market, by Product, 2027
6    Global CRISPR Technology Market, by Application, 2017
7    Global CRISPR Technology Market, by Application, 2027
8    Global CRISPR Technology Market Value, by Region, 2017 & 2027 ($Million)
9    Global CRISPR Technology Market, by Region, 2017
10    Global CRISPR Technology Market, by Region, 2027
11    Advantages of CRISPR Technology
12    CRISPR Technology Approach
13    Evolution of CRISPR Technology
14    CRISPR Technology: Areas of Interest
15    Future Potential of CRISPR Technology
16    Global CRSIPR Technology Market (2017-2027)
17    Market Dynamics
18    Competitive Landscape (January 2014-February 2018)
19    Share of Key Developments and Strategies (January 2014-February 2018)
20    Product Launch Share, by Companies
21    Joint Ventures, Partnerships, and Collaborations Share, by Companies
22    Porter’s Five Forces Analysis
23    Industry Insights (January 2014-February 2018)
24    Funding Scenario Share, by Type of Companies/Organization
25    CRISPR Technology Market, by Product
26    Global CRISPR Technology Market, by Product (2017-2027)
27    Different Designing Tools
28    Global CRISPR Technology Market, by Designing Tools (2017-2027)
29    Types of Library
30    Global CRISPR Technology Market, by Library (2017-2027)
31    Types of Controls
32    Global CRISPR Technology Market, by Control Kits (2017-2027)
33    Types of Plasmids
34    Global CRISPR Technology Market, by Plasmids (2017-2027)
35    Types of Vectors
36    Global CRISPR Technology Market, by Vectors (2017-2027)
37    Types of Proteins
38    Global CRISPR Technology Market, by Proteins (2017-2027)
39    Global CRISPR Technology Market, by Cas9 (2017-2027)
40    Global CRISPR Technology Market, by Cpf1 (2017-2027)
41    Global CRISPR Technology Market, by Others (2017-2027)
42    Global CRISPR Technology Market, by gRNA (2017-2027)
43    Global CRISPR Technology Market, by Others (2017-2027)
44    Global CRISPR Technology Market Share, by Application, 2017
45    Global CRISPR Technology Market Share, by Application, 2017
46    Global CRISPR Technology Market, by Application (2017-2027)
47    Application of CRISPR Technology in Biological Research
48    Global CRISPR Technology Market, by Biological Research (2017-2027)
49    Application of CRISPR Technology in Agricultural Research
50    Global CRISPR Technology Market, by Agricultural Biotech (2017-2027)
51    Global CRISPR Technology Market, by Industrial Biotech (2017-2027)
52    Global CRISPR Technology Market, by Therapeutics and Drug Discovery (2017-2027)
53    Global CRSIPR Technology Market, by Region (2017-2027)
54    Global CRISPR Technology Market Share, by Region (2017)
55    Global CRISPR Technology Market Share, by Region (2027)
56    North America CRISPR Technology Market (2017-2027)
57    North America CRISPR Technology Market, by Country (2017-2027)
58    The U.S. CRISPR Technology Market (2017-2027)
59    Canada CRISPR Technology Market  (2017-2027)
60    Europe CRISPR Technology Market (2017-2027)
61    The U.K. CRISPR Technology Market (2017-2027)
62    Germany CRISPR Technology Market (2017-2027)
63    France CRISPR Technology Market (2017-2027)
64    Spain CRISPR Technology Market (2017-2027)
65    Italy CRISPR Technology Market (2017-2027)
66    Switzerland CRISPR Technology Market (2017-2027)
67    Rest of the Europe CRISPR Technology Market (2017-2027)
68    Asia Pacific CRISPR Technology Market (2017-2027)
69    Japan CRISPR Technology Market (2017-2027)
70    China CRISPR Technology Market (2017-2027)
71    South Korea CRISPR Technology Market (2017-2027)
72    Singapore CRISPR Technology Market (2017-2027)
73    India CRISPR Technology Market (2017-2027)
74    Rest of Asia Pacific CRISPR Technology Market (2017-2027)
75    Rest of the World CRISPR Technology Market (2017-2027)
76    Agilent Technologies, Inc.: Overall Product Portfolio
77    Agilent Technologies, Inc.: Product Portfolio for Global CRISPR Technology
78    Agilent Technologies, Inc.: Overall Financials (2014-2017)
79    Agilent Technologies, Inc.: Revenue by Business Segment (2014-2017)
80    Agilent Technologies, Inc.: Revenue by Region (2014-2017)
81    Agilent Technologies, Inc.: Global Presence
82    Agilent Technologies, Inc.: SWOT Analysis
83    Applied StemCell, Inc.: Overall Product Portfolio
84    Applied StemCell, Inc.: Product Portfolio for Global CRISPR Technology
85    Applied StemCell, Inc.: SWOT Analysis
86    Cellecta, Inc.: Overall Product Portfolio
87    Cellecta, Inc.: Product Portfolio for Global CRISPR Technology
88    Cellecta, Inc.: SWOT Analysis
89    Horizon Discovery plc: Overall Product Portfolio
90    Horizon Discovery plc (Dharmacon, Inc.): Product Portfolio for Global CRISPR Technology
91    Horizon Discovery plc: Overall Financials (2014-2016)
92    Horizon Discovery plc: Net Revenue by Business Segment (2014-2016)
93    Horizon Discovery plc: Net Revenue by Region (2014-2016)
94    Horizon Discovery plc: Global Presence
95    Horizon Discovery plc: SWOT Analysis
96    EdiGene, Inc.: Overall Product Portfolio
97    EdiGene, Inc.: Product Portfolio for Global CRISPR Technology
98    EdiGene, Inc.: SWOT Analysis
99    GeneCopoeia, Inc.: Overall Product Portfolio
100    GeneCopoeia, Inc.: Product Portfolio for Global CRISPR Technology
101    GeneCopoeia, Inc.: SWOT Analysis
102    Genedata AG: Overall Product Portfolio
103    Genedata AG: Product Portfolio for Global CRISPR Technology
104    Genedata AG: SWOT Analysis
105    GenScript: Overall Product Portfolio
106    GenScript: Product Portfolio for Global CRISPR Technology
107    GenScript: Overall Financials (2014-2016)
108    GenScript: Net Revenue by Business Segment (2014-2016)
109    GenScript: Net Revenue by Region (2014-2016)
110    GenScript: Global Presence
111    GenScript: SWOT Analysis
112    Integrated DNA Technologies, Inc.: Overall Product Portfolio
113    Integrated DNA Technologies, Inc.: Product Portfolio for Global CRISPR Technology
114    Integrated DNA Technologies, Inc.: SWOT Analysis
115    Mirus Bio LLC : Overall Product Portfolio
116    Mirus Bio LLC: Product Portfolio for Global CRISPR Technology
117    Mirus Bio LLC: SWOT Analysis
118    New England Biolabs: Overall Product Portfolio
119    New England Biolabs: Product Portfolio for Global CRISPR Technology
120    New England Biolabs: SWOT Analysis
121    OriGene Technologies, Inc.: Overall Product Portfolio
122    OriGene Technologies, Inc.: Product Portfolio for Global CRISPR Technology
123    OriGene Technologies, Inc.: SWOT Analysis
124    Oxford Genetics Ltd.: Overall Product Portfolio
125    Oxford Genetics Ltd. : Product Portfolio for Global CRISPR Technology
126    Oxford Genetics Ltd.: SWOT Analysis
127     Rockland Immunochemicals, Inc: Overall Product Portfolio
128    Rockland Immunochemicals, Inc: Product Portfolio for Global CRISPR Technology
129    Rockland Immunochemicals, Inc: SWOT Analysis
130    Merck KGaA: Overall Product Portfolio
131    Merck KGaA (Sigma Aldrich Corporation): Product Portfolio for Global CRISPR Technology
132    Merck KGaA: Overall Financials, (2014-2016)
133    Merck KGaA: Net Revenue by Business Segments, (2014-2016)
134    Merck KGaA: Net Revenue by Geography, (2014)
135    Merck KGaA: Net Revenue by Geography, (2015-2016)
136    Merck KGaA: Global Presence
137    Merck KGaA: SWOT Analysis
138    Synthego Corporation: Overall Product Portfolio
139    Synthego Corporation: Product Portfolio for Global CRISPR Technology
140    Synthego Corporation: SWOT Analysis
141    System Biosciences, LLC: Overall Product Portfolio
142    System Biosciences, LLC: Product Portfolio for Global CRISPR Technology
143    System Biosciences, LLC: SWOT Analysis
144    Takara Bio Inc. : Overall Product Portfolio
145    Takara Bio Inc. (Takara Bio USA Inc.): Product Portfolio for Global CRISPR Technology
146    Takar Bio Inc.: Overall Financials (2014-2017)
147    Takara Bio Inc.: Net Revenue by Business Segment (2014-2017)
148    Takara Bio Inc.: Net Revenue by Region (2014-2017)
149    Takara Bio Inc.: Global Presence
150    Takara Bio Inc.: SWOT Analysis
151    Thermo Fisher Scientific Inc.: Overall Product Portfolio
152    Thermo Fisher Scientific Inc.: Product Portfolio for Global CRISPR Technology
153    Thermo Fisher Scientific Inc.: Overall Financials (2014-2017)
154    Thermo Fisher Scientific Inc.: Net Revenue by Business Segment (2014-2017)
155    Thermo Fisher Scientific Inc.: Net Revenue by Region (2014-2016)
156    Thermo Fisher Scientific Inc.: Global Presence
157    Thermo Fisher Scientific Inc.- SWOT Analysis
158    transOMIC technologies inc.: Overall Product Portfolio
159    transOMIC technologies inc.: Product Portfolio for Global CRISPR Technology
160    transOMIC technologies inc.: SWOT Analysis
161    Transposagen Biopharmaceuticals: Overall Product Portfolio
162    Transposagen Biopharmaceuticals: Product Portfolio for Global CRISPR Technology
163    Transposagen Biopharmaceuticals: SWOT Analysis
164    Global CRISPR Technology Market Segmentation
165    Considered Factors for Data Prediction & Modeling

Report Description

The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophilia, and sickle cell anaemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.

The CRISPR technology include designing tools, library, control kits, plasmids, vectors, proteins, gRNA and other products to perform the desired experiment and study the obtained results. Currently, CRISPR technology is considered a valuable tool for the biotechnology and biopharmaceutical companies to conduct cost effective and highly efficient genome editing procedures. Moreover, advancements of CRISPR technology reduced turn-around time and complexity of genome editing process. The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders. The pharmaceutical industry is witnessing the growth of pipeline of candidates developed using CRISPR technology. Several biopharmaceutical companies are now indulging in the research and development of such CRISPR based therapies. Furthermore, the advent of genome editing technologies in molecular research has enabled the companies to target the root cause of genetic and chronic diseases, with one-time procedure and develop gene therapeutics to remain competitive in the market.

The purpose of this study is to gain a holistic view of the CRISPR technology market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products associated with the global CRISPR technology market, across different regions. The market has been segmented into ‘product’, ‘application’, and ‘regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global CRISPR technology market with the help of the key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well. 

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global CRISPR technology market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment the key market trends, list of the key companies, and the key strategies and developments, have been discussed.

The key players who have been contributing significantly to the CRISPR technology market include Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., Horizon Discovery plc, EdiGene, Inc., GeneCopoeia, Inc., Genedata AG, GenScript, Integrated DNA Technologies (IDT), Inc., Mirus Bio LLC, New England Biolabs, OriGene Technologies, Inc., Oxford Genetics Ltd., Rockland Immunochemicals, Inc., Merck KGaA, Synthego Corporation, System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific, transOMIC technologies inc., and Transposagen Biopharmaceuticals, among others.

Key Questions Answered in this Report

The answers to the following key questions can be derived from this report:

•    How did the CRISPR technology market evolve, and what is its scope in the future?
•    What are the major market drivers, challenges and opportunities in the global CRISPR technology market?
•    What are the key developmental strategies that are being implemented by the key players to sustain in this market?
•    How are the influencing factors will affect the industry attractiveness?
•    How the CRISPR technology is being utilized for the development of therapeutics?
•    How the investments by public & private companies, and government organizations will affect the global CRISPR technology market? 
•    What was the market size of the leading segments and sub-segments of the global CRISPR technology market in 2017?
•    How will the industry evolve during the forecast period 2018- 2027?
•    What will be the growth rate of the CRISPR technology during the forecast period?
•    How will each segment of the global CRISPR technology market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2027?
•    Which product segment, and application segment is expected to register the highest CAGR for the CRISPR technology market?
•    What are the major benefits of the implementation of CRISPR technology in different field of applications including biological research, agricultural biotech, industrial biotech, and therapeutics & drug discovery?
•    What is the market size of CRISPR technology in different countries of the world?
•    Which geographical region will contribute to the highest sales of CRISPR technology?
•    Who are the key players in the CRISPR technology market and what are their contributions?

Market Overview

Every year, around 7.9 million children are born with genetic disorders, worldwide. Also, the genetic diseases have been responsible for 20-30% of the infant’s deaths worldwide and constitute approximately 25% of the global economic burden for diseases. The increasing economic burden of genetic diseases can be reduced by focusing on gene therapeutics supported by biomarker study, lifestyle modification, and disease screening methods that enable early detection. Furthermore, the increasing environmental factors, such as chemical factors, radioactive factors, and biological factors, has elevated the mutation rate, which elevated the need for the development of best gene therapeutic procedures, personalized medicine, and diagnostic procedures with less turnaround time. 

Several conglomerate companies and startups based out of the developed countries, such as the U.S., the U.K., Germany, China, France, and Canada, among others, have been making significant investments in the field of life sciences to develop promising gene therapy procedures to promote global health. The advent of CRISPR technology has transformed the field of genome editing by reducing the turnaround time and complexity, enhancing the accuracy, efficiency, and safety, and encouraged numerous innovations. Researchers demonstrated the potential applications of CRISPR technology to provide one-time gene therapy procedure for several genetic disorders, such as haemophilia, sickle cell anemia, and beta thalassemia, and cancers. Also, the CRISPR technology proved to repair genetic errors in an individual’s DNA, treating the root cause of the disease. Many companies, such as CRISPR Therapeutics AG, are planning to initiate clinical trials in 2018 for the treatment of various genetic disorders.

The purpose of the study is to gain a holistic view of the CRISPR technology market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the products associated with the global CRISPR technology market, across different regions. The global CRISPR technology market is segmented into three different parts namely by product, by application, and by region. The global market value was estimated using these three different approaches and was validated with one another. The global CRISPR technology market is expected to reach $10.55 billion by 2027. 

With the increasing demand for advancements in application specific products across the various segments of the CRISPR technology, the CRISPR technology market is expected to witness rapid growth in the future. Further, the swift expansion of the gene therapy procedures in the developed markets such as the U.S., Japan, Germany, and the U.K. is the key driver for growth of the CRISPR technology market. Moreover, the plasmids sub-segment dominated the global CRISPR technology market in 2017 in terms of products. However, the proteins sub segment is anticipated to witness the highest CAGR during the forecast period. The therapeutics and drug discovery application specific CRISPR technology witnessed the highest industry demand. Besides, the CRISPR technology specific to industrial biotech are also expected to witness impressive CAGR during the forecast period.

Based on the region the global CRISPR technology market is segmented into North America, Europe, Asia Pacific and Rest of the World (RoW). North America is the leading contributor to the global CRISPR technology market and contributed 39% of the global market values in 2017. However, Europe is expected to grow at a CAGR of 36.80% during the forecast period followed by Asia Pacific region.

The key players who have significant contributions to the global CRISPR technology market are Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., Horizon Discovery plc, EdiGene, Inc., GeneCopoeia, Inc., Genedata AG, GenScript, Integrated DNA Technologies (IDT), Inc., Mirus Bio LLC, New England Biolabs, OriGene Technologies, Inc., Oxford Genetics Ltd., Rockland Immunochemicals, Inc., Merck KGaA, Synthego Corporation, System Biosciences, LLC, Thermo Fisher Scientific, transOMIC technologies inc., and Transposagen Biopharmaceuticals, among others.

You may also like

Published Year:2021

Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Coun

The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to...

Published Year:2018

Global Regenerative Medicines Market - Analysis and Forecast (2017-2025): (Focus on Therapy, Applica

The global regenerative medicines market is expected to reach $50.55 billion by...

Published Year:2017

Global Next Generation Sequencing (NGS) Market - Analysis and Forecast (2017-2024) : (Focus on Produ

(Focus on Product Type, Technology, Application, Country Analysis, Market Share Analysis,...

Published Year:2017

Global Precision Medicine Market – Analysis and Forecast (2017-2026): (Focus on Ecosystem Player,

The global precision medicine market was dominated by the oncology segment in 2016. The...

Global CRISPR Technology Market

Focus on Product, Applications, Geographical Analysis, Industry Insights And Competitive Landscape - Analysis And Forecast (2018-2027)

Contact Us

Get Free SampleSchedule a Call